US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3701

-0.0316-7.87%

Volume:334.62K

Turnover:132.97K

Market Cap:59.25M

PE:-0.45

High:0.4400

Open:0.4122

Low:0.3700

Close:0.4017

Loading ...

Overview Company News Filings

Renovaro Agrees to Merge With BioSymetrics

MT Newswires Live

Renovaro Biosciences Buys AI-Driven BioSymetrics

BRIEF-Renovaro & Biosymetrics Announce Definitive Merger Agreement

Renovaro and Biosymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

THOMSON REUTERS

Renovaro: Deal Expected to Close in March 2025

THOMSON REUTERS

Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine

Renovaro Gets $15 Million in Equity Committed; Shares Rise

MT Newswires Live

Renovaro Announces $15 Million in Equity Committed

THOMSON REUTERS

Renovaro Announces $15 million in Equity Committed

BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows

Renovaro - to Restate Affected Financial Statements

THOMSON REUTERS

Renovaro - Some of Co's Financial Statements Should No Longer Be Relied Upon

THOMSON REUTERS

Renovaro Names Nathen Fuentes as CFO

MT Newswires Live

Renovaro Taps Nathen Fuentes as Finance Chief

Renovaro BioSciences issues shareholder letter, provides corporate update

Renovaro BioSciences appoints Fuentes as Chief Financial Officer

Renovaro Issues Shareholder Letter and Provides Corporate Update

THOMSON REUTERS

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

THOMSON REUTERS

Renovaro Issues Shareholder Letter and Provides Corporate Update

Press Release: Renovaro Appoints Nathen Fuentes as Chief Financial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RENB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","market":"US","secType":"STK","nameCN":"RENOVARO BIOSCIENCES INC","latestPrice":0.3701,"timestamp":1745345067675,"preClose":0.4017,"halted":0,"volume":334616,"delay":0,"floatShares":78893422,"shares":160086097,"eps":-0.821613,"marketStatus":"Trading","change":-0.0316,"latestTime":"04-22 14:05:20 EDT","open":0.4122,"high":0.44,"low":0.37,"amount":132967.18976767999,"amplitude":0.174259,"askPrice":0.3702,"askSize":275,"bidPrice":0.3701,"bidSize":310,"shortable":3,"etf":0,"ttmEps":-0.821613,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4017,"preHourTrading":{"tag":"盘前","latestPrice":0.4,"preClose":0.4017,"latestTime":"09:29 EDT","volume":6800,"amount":2801.52248,"timestamp":1745328567727},"postHourTrading":{"tag":"盘后","latestPrice":0.404,"preClose":0.4017,"latestTime":"19:53 EDT","volume":7833,"amount":3162.7392,"timestamp":1745279609248},"volumeRatio":0.788623,"impliedVol":0.3452,"impliedVolPercentile":0.088},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RENB\",,,,,undefined,":{"symbol":"RENB","floatShares":78893422,"roa":"-18.09%","roe":"-188.47%","lyrEps":-0.83794,"volumeRatio":0.788623,"shares":160086097,"dividePrice":0,"high":0.44,"amplitude":0.174259,"preClose":0.4017,"low":0.37,"week52Low":0.3214,"pbRate":"0.72","week52High":2.34,"institutionHeld":0,"latestPrice":0.3701,"committee":0.059829,"eps":-0.821613,"divideRate":0,"volume":334616,"delay":0,"ttmEps":-0.821613,"open":0.4122,"prevYearClose":0.8355,"prevWeekClose":0.3526,"prevMonthClose":0.5432,"prevQuarterClose":0.5432,"fiveDayClose":0.3585,"twentyDayClose":0.7185,"sixtyDayClose":0.8906},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RENB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514986964","title":"Renovaro Agrees to Merge With BioSymetrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514986964","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514986964?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:46","pubTimestamp":1740595584,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) said Wednesday it agreed to a merger with artificial intelligence-driven drug discovery company BioSymetrics.Financial terms of the transaction were not disclosed.The company said it e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514520869","title":"Renovaro Biosciences Buys AI-Driven BioSymetrics","url":"https://stock-news.laohu8.com/highlight/detail?id=2514520869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514520869?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:44","pubTimestamp":1740595440,"startTime":"0","endTime":"0","summary":"Renovaro Biosciences said Wednesday that it is buying BioSymetrics, an artificial intelligence-driven drug discovery and biomarker identification company.Renovaro said the transaction will improve its data repository, biomarker discovery capabilities and accelerate translational research.BioSymetrics' proprietary platform is called Elion, an AI and machine learning engine that uncovers complex biological relationships to speed up the discovery of diagnostics and therapeutics. Its Phenograph platform provides a translational engine that maps human clinical signals to prioritized therapeutic targets.Renovaro said that through this merger, it will gain access to cutting-edge computational tools that enhance the ability to stratify patients, predict treatment responses, and drive more effective therapeutic interventions.The transaction is expected to close in March, subject to customary closing conditions and regulatory approvals.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514086614","title":"BRIEF-Renovaro & Biosymetrics Announce Definitive Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086614","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514086614?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:27","pubTimestamp":1740594460,"startTime":"0","endTime":"0","summary":"BRIEF-Renovaro & Biosymetrics Announce Definitive Merger AgreementFeb 26 (Reuters) - Renovaro Inc RENB.O:RENOVARO AND BIOSYMETRICS ANNOUNCE DEFINITIVE MERGER AGREEMENT TO ADVANCE AI-DRIVEN BIOMARKER D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514925866","title":"Renovaro and Biosymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514925866","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514925866?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514661218","title":"Renovaro: Deal Expected to Close in March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514661218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514661218?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594306,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0ZY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514866124","title":"Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2514866124","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514866124?lang=en_us&edition=fundamental","pubTime":"2025-02-27 02:25","pubTimestamp":1740594300,"startTime":"0","endTime":"0","summary":"Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine. Strategic Combination Aims to Accelerate Biomarker Identification, Enhance Drug Discovery, and Expand Precision Medicine Applications in Cancer and Beyond. LOS ANGELES, Feb. 26, 2025  -- Renovaro Biosciences Inc. , a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, today announced a definitive agreement to merge with BioSymetrics, an artificial intelligence -driven drug discovery and biomarker identification company. This transformative partnership is designed to enhance Renovaro's data repository, biomarker discovery capabilities, accelerate translational research, and bring precision medicine solutions to cancer and other critical disease areas.\"This merger represents a pivotal step in our mission to diagnose cancer and advance precision medicine,\" said David Weinstein, CEO of Renovaro. \"By com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2514170852","title":"Renovaro Gets $15 Million in Equity Committed; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2514170852","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514170852?lang=en_us&edition=fundamental","pubTime":"2025-02-26 23:57","pubTimestamp":1740585475,"startTime":"0","endTime":"0","summary":"Renovaro  said Wednesday it has $15 million in additional equity committed at $1 per share.The company also said it has one privately placed cash warrant exercisable at $1.50 with a one year term.The shares were up more than 17% in recent trading.Price: 0.91, Change: +0.14, Percent Change: +17.72","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","EQR","BK4588","BK4139","RENB","BK4215"],"gpt_icon":0},{"id":"2514853471","title":"Renovaro Announces $15 Million in Equity Committed","url":"https://stock-news.laohu8.com/highlight/detail?id=2514853471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514853471?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:15","pubTimestamp":1740579309,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250226:nFWN3PH0U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2514685374","title":"Renovaro Announces $15 million in Equity Committed","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685374","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514685374?lang=en_us&edition=fundamental","pubTime":"2025-02-26 22:15","pubTimestamp":1740579300,"startTime":"0","endTime":"0","summary":"LOS ANGELES, Feb.  26, 2025  (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announces that it has $15 mill","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3033011/0/en/Renovaro-Announces-15-million-in-Equity-Committed.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","EQR","BK4215","BK4585","RENB"],"gpt_icon":0},{"id":"2512748672","title":"BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing Shows","url":"https://stock-news.laohu8.com/highlight/detail?id=2512748672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512748672?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:36","pubTimestamp":1739979373,"startTime":"0","endTime":"0","summary":"BRIEF-Some Of Renovaro's Financial Statements Contain Material Misstatements, SEC Filing ShowsFeb 19 (Reuters) - Renovaro Inc RENB.O:RENOVARO - SOME OF CO'S  FINANCIAL STATEMENTS SHOULD NO LONGER BE R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2512399107","title":"Renovaro - to Restate Affected  Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2512399107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512399107?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:49","pubTimestamp":1739972996,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2512073131","title":"Renovaro - Some of Co's  Financial Statements Should No Longer Be Relied Upon","url":"https://stock-news.laohu8.com/highlight/detail?id=2512073131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512073131?lang=en_us&edition=fundamental","pubTime":"2025-02-19 21:49","pubTimestamp":1739972996,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA0M7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2501783819","title":"Renovaro Names Nathen Fuentes as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2501783819","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501783819?lang=en_us&edition=fundamental","pubTime":"2025-01-07 23:02","pubTimestamp":1736262170,"startTime":"0","endTime":"0","summary":"Renovaro  said Tuesday it has appointed Nathen Fuentes as chief financial officer, replacing interim CFO Simon Tarsh.Fuentes, whose appointment took effect Jan. 2, was previously CFO at Telomir Pharmaceuticals , Renovaro said.Renovaro shares rose 3% in recent Tuesday trading.Price: 1.03, Change: +0.03, Percent Change: +3.30","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RENB","BK4007","BK4139","TELO"],"gpt_icon":0},{"id":"2501007992","title":"Renovaro Taps Nathen Fuentes as Finance Chief","url":"https://stock-news.laohu8.com/highlight/detail?id=2501007992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501007992?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:49","pubTimestamp":1736261340,"startTime":"0","endTime":"0","summary":"Renovaro said it named Nathen Fuentes as its permanent finance chief to succeed interim CFO Simon Tarsh.The cancer diagnostics and therapeutics company on Tuesday said Fuentes, who previously served as CFO of Telomir Pharmaceuticals, has experience leading acquisition and organic growth initiatives.The Los Angeles-based company on Monday agreed to acquire Predictive Oncology, which owns a database of 150,000 frozen and live tumor samples and more than 20 years of drug-response data.In a letter to shareholders, Chief Executive David Weinstein also said Nasdaq notified the company it is now in good standing.He added that the company has now \"taken critical steps in building a point of care cancer detection and vaccine company and will continue to update you regularly on our progress.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2501820082","title":"Renovaro BioSciences issues shareholder letter, provides corporate update","url":"https://stock-news.laohu8.com/highlight/detail?id=2501820082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501820082?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:31","pubTimestamp":1736260268,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) issued a letter to shareholders from Chief Executive Officer David Weinstein. “As we enter the new year, I wanted to update you on ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-issues-shareholder-letter-provides-corporate-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-issues-shareholder-letter-provides-corporate-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2501200685","title":"Renovaro BioSciences appoints Fuentes as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501200685","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501200685?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:26","pubTimestamp":1736259991,"startTime":"0","endTime":"0","summary":"Renovaro (RENB) announced the appointment of Nathen Fuentes, CPA, as Chief Financial Officer effective January 2, 2025, replacing interim CFO Simon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-appoints-fuentes-as-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovaro-biosciences-appoints-fuentes-as-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2501024662","title":"Renovaro Issues Shareholder Letter and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2501024662","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501024662?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:15","pubTimestamp":1736259301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA8DYQCK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RENB","POAI","BK4139","BK4198","BK4082"],"gpt_icon":0},{"id":"2501024602","title":"Renovaro Appoints Nathen Fuentes as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501024602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501024602?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:15","pubTimestamp":1736259301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250107:nTUA8B9NXK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RENB"],"gpt_icon":0},{"id":"2501320738","title":"Renovaro Issues Shareholder Letter and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2501320738","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501320738?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:15","pubTimestamp":1736259300,"startTime":"0","endTime":"0","summary":"Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan.  07, 2025  (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/07/3005542/0/en/Renovaro-Issues-Shareholder-Letter-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4139","RENB","POAI","BK4198"],"gpt_icon":0},{"id":"2501024212","title":"Press Release: Renovaro Appoints Nathen Fuentes as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501024212","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501024212?lang=en_us&edition=fundamental","pubTime":"2025-01-07 22:15","pubTimestamp":1736259300,"startTime":"0","endTime":"0","summary":"Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives. LOS ANGELES, Jan. 07, 2025  -- Renovaro Inc. , a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced the appointment of Nathen Fuentes, CPA, as Chief Financial Officer effective January 2, 2025, replacing interim CFO Simon Tarsh.Mr. Fuentes added, \"I am excited to be appointed as CFO as we prepare Renovaro to realize its potential to offer cancer patients early diagnosis, a treatment protocol, and recurrence monitoring. I look forward to working with David, the senior leadership team, and our finance team as we continue to execute on our strategic and financial priorities and our commitments to all shareholders.\". Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted trea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RENB","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":68,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-19","symbol":"RENB","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739941200000,"reportTimeType":"post","actualEps":-0.02},{"market":"US","date":"2024-11-14","symbol":"RENB","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2024-10-10","symbol":"RENB","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1728532800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2024-05-15","symbol":"RENB","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2024-02-14","symbol":"RENB","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707886800000,"reportTimeType":"post","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RENB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RENB","date":"2025-04-21","current":-0.476701,"percent":0.997512,"low":-11.254936,"twenty":-6.927186,"median":-2.162652,"eighty":-1.030478,"high":-0.427977,"avg":-3.594354,"sd":2.943931,"marketCap":56446357},"quantilePoints":[{"date":"2023-08-11","current":-0.842296,"twenty":-0.858231,"median":-0.663023,"eighty":-0.461441,"marketCap":89892200},{"date":"2023-08-18","current":-0.921973,"twenty":-0.901484,"median":-0.882134,"eighty":-0.681804,"marketCap":98395516},{"date":"2023-08-25","current":-1.38865,"twenty":-1.080188,"median":-0.904899,"eighty":-0.830914,"marketCap":148200654},{"date":"2023-09-01","current":-1.781342,"twenty":-1.390926,"median":-1.024414,"eighty":-0.866199,"marketCap":190109855},{"date":"2023-09-08","current":-1.838254,"twenty":-1.738089,"median":-1.138238,"eighty":-0.882134,"marketCap":196183652},{"date":"2023-09-15","current":-1.804107,"twenty":-1.831424,"median":-1.371576,"eighty":-0.88441,"marketCap":192539374},{"date":"2023-09-22","current":-2.191108,"twenty":-1.848498,"median":-1.479709,"eighty":-0.901484,"marketCap":233841196},{"date":"2023-09-29","current":-2.316314,"twenty":-1.946387,"median":-1.676055,"eighty":-0.933355,"marketCap":247203550},{"date":"2023-10-06","current":-7.118779,"twenty":-2.179726,"median":-1.781342,"eighty":-0.980023,"marketCap":282502019},{"date":"2023-10-13","current":-7.74788,"twenty":-5.197793,"median":-1.82118,"eighty":-1.031244,"marketCap":307467313},{"date":"2023-10-20","current":-5.711578,"twenty":-7.168445,"median":-1.855328,"eighty":-1.080188,"marketCap":226658596},{"date":"2023-10-27","current":-4.635484,"twenty":-7.135334,"median":-1.855328,"eighty":-1.118888,"marketCap":183954803},{"date":"2023-11-03","current":-5.049366,"twenty":-7.026069,"median":-1.943541,"eighty":-1.206532,"marketCap":200379339},{"date":"2023-11-10","current":-4.689234,"twenty":-6.615498,"median":-2.10574,"eighty":-1.302144,"marketCap":186087821},{"date":"2023-11-17","current":-4.561671,"twenty":-5.969841,"median":-2.191108,"eighty":-1.374991,"marketCap":187755275},{"date":"2023-11-24","current":-5.396221,"twenty":-5.585435,"median":-2.219564,"eighty":-1.390926,"marketCap":222104819},{"date":"2023-12-01","current":-5.396221,"twenty":-5.49345,"median":-4.524078,"eighty":-1.428488,"marketCap":222104819},{"date":"2023-12-08","current":-5.444836,"twenty":-5.444836,"median":-4.635484,"eighty":-1.545727,"marketCap":224105763},{"date":"2023-12-15","current":-5.720319,"twenty":-5.636053,"median":-4.686221,"eighty":-1.656136,"marketCap":235444448},{"date":"2023-12-22","current":-5.412426,"twenty":-5.636053,"median":-4.701705,"eighty":-1.675486,"marketCap":222771800},{"date":"2023-12-29","current":-5.169353,"twenty":-5.606885,"median":-4.76643,"eighty":-1.678901,"marketCap":212767079},{"date":"2024-01-05","current":-5.847089,"twenty":-5.626331,"median":-4.823692,"eighty":-1.699389,"marketCap":240662238},{"date":"2024-01-12","current":-7.088371,"twenty":-5.780749,"median":-4.953966,"eighty":-1.754024,"marketCap":291752546},{"date":"2024-01-19","current":-7.349693,"twenty":-6.206408,"median":-5.070988,"eighty":-1.790448,"marketCap":302508400},{"date":"2024-01-26","current":-7.962168,"twenty":-7.106616,"median":-5.169353,"eighty":-1.810936,"marketCap":327717433},{"date":"2024-02-02","current":-7.072038,"twenty":-7.137369,"median":-5.263632,"eighty":-1.82118,"marketCap":291080305},{"date":"2024-02-09","current":-5.896087,"twenty":-7.137369,"median":-5.347607,"eighty":-1.82801,"marketCap":242678961},{"date":"2024-02-16","current":-6.969,"twenty":-7.137369,"median":-5.363812,"eighty":-1.845084,"marketCap":287336744},{"date":"2024-02-23","current":-6.969,"twenty":-7.150435,"median":-5.387578,"eighty":-1.855328,"marketCap":287336744},{"date":"2024-03-01","current":-8.990011,"twenty":-7.198517,"median":-5.396221,"eighty":-1.861019,"marketCap":370664399},{"date":"2024-03-08","current":-10.418656,"twenty":-7.379651,"median":-5.404324,"eighty":-1.89289,"marketCap":429568432},{"date":"2024-03-15","current":-10.906486,"twenty":-7.477571,"median":-5.444836,"eighty":-1.935004,"marketCap":449682004},{"date":"2024-03-22","current":-10.244431,"twenty":-7.594683,"median":-5.466304,"eighty":-1.975981,"marketCap":422385013},{"date":"2024-03-28","current":-9.721756,"twenty":-7.6659,"median":-5.49345,"eighty":-2.048828,"marketCap":400834757},{"date":"2024-04-05","current":-9.721756,"twenty":-7.780991,"median":-5.585767,"eighty":-2.162652,"marketCap":400834757},{"date":"2024-04-12","current":-8.537025,"twenty":-7.909815,"median":-5.683539,"eighty":-2.162652,"marketCap":351987511},{"date":"2024-04-19","current":-8.01435,"twenty":-8.049195,"median":-5.736523,"eighty":-2.191108,"marketCap":330437255},{"date":"2024-04-26","current":-5.92365,"twenty":-8.01435,"median":-5.889227,"eighty":-2.196799,"marketCap":244236232},{"date":"2024-05-03","current":-5.191905,"twenty":-7.962168,"median":-5.736523,"eighty":-2.219564,"marketCap":214065874},{"date":"2024-05-10","current":-4.1814,"twenty":-7.909815,"median":-5.683539,"eighty":-2.316314,"marketCap":172402046},{"date":"2024-05-17","current":-2.443812,"twenty":-7.872338,"median":-5.585767,"eighty":-2.443812,"marketCap":131786997},{"date":"2024-05-24","current":-3.61057,"twenty":-7.790675,"median":-5.49948,"eighty":-2.523736,"marketCap":194706526},{"date":"2024-05-31","current":-4.020862,"twenty":-7.782928,"median":-5.490611,"eighty":-2.561678,"marketCap":216832267},{"date":"2024-06-07","current":-3.637923,"twenty":-7.780991,"median":-5.444836,"eighty":-2.581602,"marketCap":196181575},{"date":"2024-06-14","current":-3.966156,"twenty":-7.761124,"median":-5.43582,"eighty":-2.609206,"marketCap":213882168},{"date":"2024-06-21","current":-3.938803,"twenty":-7.742964,"median":-5.412426,"eighty":-2.63681,"marketCap":212407119},{"date":"2024-06-28","current":-4.10292,"twenty":-7.738048,"median":-5.396221,"eighty":-2.647751,"marketCap":221257416},{"date":"2024-07-05","current":-4.321743,"twenty":-7.714683,"median":-5.396221,"eighty":-2.94281,"marketCap":233057811},{"date":"2024-07-12","current":-3.966156,"twenty":-7.699226,"median":-5.387578,"eighty":-3.371454,"marketCap":213882168},{"date":"2024-07-15","current":-3.966156,"twenty":-7.69872,"median":-5.380016,"eighty":-3.449983,"marketCap":213882168},{"date":"2024-08-02","current":-1.91497,"twenty":-7.698214,"median":-5.371914,"eighty":-3.135869,"marketCap":103268211},{"date":"2024-08-09","current":-1.773009,"twenty":-7.6659,"median":-5.347607,"eighty":-2.571163,"marketCap":95612704},{"date":"2024-08-16","current":-1.858076,"twenty":-7.631055,"median":-5.298934,"eighty":-2.219564,"marketCap":100200108},{"date":"2024-08-23","current":-1.800361,"twenty":-7.615438,"median":-5.234173,"eighty":-2.162652,"marketCap":97087754},{"date":"2024-08-30","current":-1.096953,"twenty":-7.594683,"median":-5.191905,"eighty":-1.942322,"marketCap":96659989},{"date":"2024-09-06","current":-0.956172,"twenty":-7.594683,"median":-5.169353,"eighty":-1.883292,"marketCap":84254824},{"date":"2024-09-13","current":-1.039201,"twenty":-7.568029,"median":-5.122215,"eighty":-1.855328,"marketCap":91571069},{"date":"2024-09-20","current":-0.898922,"twenty":-7.561365,"median":-5.068368,"eighty":-1.82118,"marketCap":79210154},{"date":"2024-09-27","current":-0.801832,"twenty":-7.538402,"median":-4.941343,"eighty":-1.780605,"marketCap":70654868},{"date":"2024-10-04","current":-0.840501,"twenty":-7.499872,"median":-4.812365,"eighty":-1.72119,"marketCap":74062232},{"date":"2024-10-11","current":-0.852916,"twenty":-7.482618,"median":-4.731822,"eighty":-1.672382,"marketCap":68787798},{"date":"2024-10-18","current":-1.441668,"twenty":-7.469223,"median":-4.689234,"eighty":-1.611745,"marketCap":116270748},{"date":"2024-10-25","current":-0.987903,"twenty":-7.425307,"median":-4.683207,"eighty":-1.393203,"marketCap":79674514},{"date":"2024-10-31","current":-1.045809,"twenty":-7.406141,"median":-4.602373,"eighty":-1.33948,"marketCap":84344712},{"date":"2024-11-08","current":-1.091709,"twenty":-7.392372,"median":-4.486173,"eighty":-1.206786,"marketCap":88046508},{"date":"2024-11-15","current":-0.800809,"twenty":-7.364672,"median":-4.349095,"eighty":-1.204333,"marketCap":92643312},{"date":"2024-11-22","current":-0.687074,"twenty":-7.320294,"median":-4.29439,"eighty":-1.148518,"marketCap":79485644},{"date":"2024-11-29","current":-1.037745,"twenty":-7.274563,"median":-4.196865,"eighty":-1.139226,"marketCap":120053797},{"date":"2024-12-06","current":-1.975612,"twenty":-7.221841,"median":-4.130273,"eighty":-1.130296,"marketCap":228552972},{"date":"2024-12-13","current":-2.359759,"twenty":-7.19548,"median":-4.075567,"eighty":-1.139226,"marketCap":272993828},{"date":"2024-12-20","current":-2.119667,"twenty":-7.179834,"median":-4.020862,"eighty":-1.141284,"marketCap":245218293},{"date":"2024-12-27","current":-1.243675,"twenty":-7.166767,"median":-4.020862,"eighty":-1.14292,"marketCap":143877270},{"date":"2025-01-03","current":-1.046937,"twenty":-7.153701,"median":-3.966156,"eighty":-1.14215,"marketCap":121117203},{"date":"2025-01-10","current":-1.144209,"twenty":-7.140635,"median":-3.966156,"eighty":-1.143797,"marketCap":132370263},{"date":"2025-01-17","current":-1.028965,"twenty":-7.137369,"median":-3.938144,"eighty":-1.135591,"marketCap":119038006},{"date":"2025-01-24","current":-1.426831,"twenty":-7.127569,"median":-3.911451,"eighty":-1.121942,"marketCap":165066035},{"date":"2025-01-31","current":-1.049818,"twenty":-7.119682,"median":-3.884098,"eighty":-1.119209,"marketCap":121450510},{"date":"2025-02-07","current":-0.921952,"twenty":-7.100534,"median":-3.630902,"eighty":-1.092825,"marketCap":106658053},{"date":"2025-02-14","current":-1.017989,"twenty":-7.088371,"median":-3.528511,"eighty":-1.069204,"marketCap":117768267},{"date":"2025-02-21","current":-1.135052,"twenty":-7.081838,"median":-2.653222,"eighty":-1.076928,"marketCap":134401986},{"date":"2025-02-28","current":-1.347103,"twenty":-7.065505,"median":-2.598891,"eighty":-1.076928,"marketCap":159511096},{"date":"2025-03-07","current":-1.131299,"twenty":-7.048899,"median":-2.565552,"eighty":-1.088965,"marketCap":133957577},{"date":"2025-03-14","current":-1.060525,"twenty":-7.03869,"median":-2.436084,"eighty":-1.088965,"marketCap":125577293},{"date":"2025-03-21","current":-0.927155,"twenty":-7.03869,"median":-2.359759,"eighty":-1.067398,"marketCap":109784900},{"date":"2025-03-28","current":-0.870591,"twenty":-7.024371,"median":-2.291162,"eighty":-1.047047,"marketCap":103087022},{"date":"2025-04-04","current":-0.635556,"twenty":-6.989335,"median":-2.250002,"eighty":-1.040362,"marketCap":75256474},{"date":"2025-04-11","current":-0.49022,"twenty":-6.969,"median":-2.193954,"eighty":-1.037745,"marketCap":58047218},{"date":"2025-04-17","current":-0.486705,"twenty":-6.948093,"median":-2.165169,"eighty":-1.032556,"marketCap":57630994},{"date":"2025-04-21","current":-0.476701,"twenty":-6.927186,"median":-2.162652,"eighty":-1.030478,"marketCap":56446357}],"updateTime":1745320601398}}}